Bioinformatics identification of a T‐cell‐related signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma
IET Systems Biology · 2023
DOI: 10.1049/syb2.12082 ↗Kurz gefasst
Fachartikel in der Zeitschrift IET Systems Biology, 2023. Verfasst von Dianqian Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Health Science Center, Ningbo University, Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ningbo Health Technology Project.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is a fatal disease with poor clinical outcomes. T cells play a vital role in the crosstalk between the tumour microenvironment and HCC. Single‐cell RNA sequencing data were downloaded from the GSE149614 dataset. The T‐cell‐related prognostic signature (TRPS) was developed with the integrative procedure including 10 machine learning algorithms. The TRPS was established using 7 T‐cell‐related markers in the Cancer Genome Atlas cohort with 1‐, 2‐ and 3‐year area under curve values of 0.820, 0.725 and 0.678, respectively. TRPS acted as an independent risk factor for HCC patients. HCC patients with a high TRPS‐based risk score had a higher Tumour Immune Dysfunction and Exclusion score, lower PD1 and CTLA4 immunophenoscore and lower level of immunoactivated cells, including CD8 + T cells and NK cells. The response rate was significantly higher in patients with low‐risk scores in immunotherapy cohorts, including IMigor210 and GSE91061. The TRPS‐based nomogram had a relatively good predictive value in evaluating the mortality risk at 1, 3 and 5 years in HCC. Overall, this study develops a TRPS by integrated bioinformatics analysis. This TRPS acted as an independent risk factor for the OS rate of HCC patients. It can screen for HCC patients who might benefit from immunotherapy, chemotherapy and targeted therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health Science Center, Ningbo University, Ningbo, Zhejiang, China.
- Department of Thoracic Surgery, The People's Hospital of Beilun District, Ningbo, Zhejiang, China.
- Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
- Department of Hepatobiliary Surgery, The People's Hospital of Beilun District, Ningbo, Zhejiang, China.
ORCID-Profile: Yunsheng Qin
Förderung
- Ningbo Health Technology Project
Zitieren
APA
Wang, D., Ding, D., Ying, J., & Qin, Y. (2023). Bioinformatics identification of a T‐cell‐related signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma. IET Systems Biology. https://doi.org/10.1049/syb2.12082
Vancouver
Wang D, Ding D, Ying J, Qin Y. Bioinformatics identification of a T‐cell‐related signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma. IET Systems Biology. 2023. doi:10.1049/syb2.12082
BibTeX
@article{Wang2023,
author = {Wang, Dianqian and Ding, Dongxiao and Ying, Junjie and Qin, Yunsheng},
title = {Bioinformatics identification of a T‐cell‐related signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma},
journal = {IET Systems Biology},
year = {2023},
doi = {10.1049/syb2.12082}
}
EUVIMED